Reactions Weekly

, Volume 1633, Issue 1, pp 139–139 | Cite as

Bosutinib/imatinib/nilotinib withdrawal

Central nervous system disorders and peripheral artery occlusive disease: 3 case reports
Case report


  1. Claudiani S, et al. Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia. American Journal of Hematology 91: E480-E481, No. 11, Nov 2016. Available from: URL: - United KingdomCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations